BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 18, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 7, 1998
View Archived Issues
Therapeutic Antibodies updates pipeline
Read More
Company Profile: PPL Therapeutics
Read More
Elan updates nicotine patch studies and its late-stage development pipeline
Read More
VIMRx and Columbia terminate research agreements
Read More
Pfizer: analysts' meeting highlights
Read More
Potent antifungal triazoles reported by Sankyo
Read More
Astra claims novel NOS inhibitors for asthma, rheumatoid arthritis and pain
Read More
Central muscarinic receptor agonists patented by U. of Toledo
Read More
Phase II clinical trial demonstrates ALX1-11 effective in treating osteoporosis
Read More
Novel compounds from P&G behave as alpha2-adrenoceptor agonists
Read More
Japanese lab prepares new, broad-spectrum carbapenems
Read More
Biomira initiates pivotal phase III trial of Theratope vaccine
Read More
StressGen's protein fusion vaccines elicit potent immune response without additional adjuvants
Read More
CuraGen, Glaxo Wellcome initiate collaborative pharmacogenomics-based drug discovery effort
Read More
Patent covering cytokine trap technology issued to Regeneron
Read More
Isis patents antisense oligonucleotides for cancer treatment
Read More
FDA approves Sandostatin LAR once-monthly depot formulation
Read More
PSC-833 plus chemotherapy is safe and effective in older patients with AML
Read More
Safer and more effective SERM compounds reported in development at Signal
Read More
Photogen initiates development of ocular disease Rx; receives U.S. patents for technology
Read More
